Research output per year
Research output per year
- 1 - 50 out of 69 results
Search results
-
2024
Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA
BSRBR-RA Contributors Group, 14 Sept 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England).Research output: Contribution to journal › Article › peer-review
-
Potential impact of European Medicines Agency measures to minimise risk of serious side effects on JAKi prescribing and utilisation in the UK
Tian, Z., Kearsley-Fleet, L., Galloway, J., Watson, K., Lunt, M., BSRBR-RA Contributors Group & Hyrich, K. L., 15 May 2024, In: Rheumatology. keae279.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
Kearsley-Fleet, L., Rokad, A., Tsoi, M. F., Zhao, S., Lunt, M., Watson, K., BSRBR-RA Contributors Group & Hyrich, K., 21 Mar 2023, In: Rheumatology (Print). kead127.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?
Lauper, K., Kearsley-Fleet, L., Galloway, J., Watson, K., Hyrich, K. & Lunt, M., 18 Oct 2023, In: Rheumatology. 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
OA01 No difference in risk of myocardial infarction among patients receiving either IL6 or TNF inhibitors for rheumatoid arthritis
Tian, Z., Kearsley-Fleet, L., Lauper, K., Haughton, S., Watson, K., Lunt, M., Mclaughlin, J., Verma, A. & Hyrich, K. L., 4 Feb 2023, In: Rheumatology. 62, Supplement_2Research output: Contribution to journal › Article › peer-review
-
Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 RA patients: A matched-analysis of the BSRBR-RA.
Kearsley-Fleet, L., Rokad, A., Tsoi, M. F., Zhao, S. S., Lunt, M., Watson, K., BSRBR-RA Contributors Group & Hyrich, K., 6 Sept 2023, In: Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis
Zhao, S. S., Rogers, K., Kearsley-Fleet, L., Watson, K., Bosworth, A., Galloway, J., Verstappen, S., Plant, D., BSRBR-RA Contributors Group, BRAGGSS, Barton, A., Hyrich, K. L. & Humphreys, J. H., 2 Jun 2023, In: Rheumatology.Research output: Contribution to journal › Article › peer-review
Open AccessFile14 Downloads (Pure) -
2022
Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
Zhao, S. S., Kearsley-Fleet, L., Bosworth, A., Watson, K., BSRBR-RA Contributors Group & Hyrich, K. L., 1 Dec 2022, In: Rheumatology (Print). 61, 12, p. 4678-4686 9 p., keac190.Research output: Contribution to journal › Article › peer-review
Open Access -
2019
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
BSRBR-RA Control Centre Consortium, 5 Aug 2019, In: Rheumatology (Oxford).Research output: Contribution to journal › Article › peer-review
Open Access -
Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register
Fagerli, K. M., Kearsley-Fleet, L., Mercer, L. K., Watson, K., Packham, J., Symmons, D. P. M., Hyrich, K. L. & British Society for Rheumatology Biologics Register, 1 Jan 2019, In: Rheumatology (Oxford, England). 58, 1, p. 80-85Research output: Contribution to journal › Article › peer-review
Open Access -
2018
Biologic Refractory Disease in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Kearsley-Fleet, L., Davies, R., De Cock, D., Watson, K., Lunt, M., Buch, M., Isaacs, J. D., Hyrich, K. & BSRBR-RA Contributors Group, Oct 2018, In: Annals of the rheumatic diseases. 77, 10, p. 1405-1412Research output: Contribution to journal › Article › peer-review
Open Access -
Long-Term Persistence of TNF-Inhibitor Treatment in Patients with Psoriatic Arthritis. Data from the British Society for Rheumatology Biologics Register.
Fagerli, K. M., Kearsley-Fleet, L., Watson, K., Packham, J., BSRBR-RA Contributors Group, Symmons, D. & Hyrich, K., 2018, In: RMD Open. 4, 1, p. e000596 e000596.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term Persistence with Rituximab in Patients with Rheumatoid Arthritis
Oldroyd, A., Symmons, D., Sergeant, J., Kearsley-Fleet, L., Watson, K., Lunt, M., Hyrich, K. & BSRBR-RA Contributors Group, Jun 2018, In: Rheumatology. 57, 6, p. 1089-1096Research output: Contribution to journal › Article › peer-review
Open Access -
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Silva-Fernandez, L., Decock, D., Lunt, M., Low, A., Watson, K., BSRBR-RA Contributors Group, Symmons, D. & Hyrich, K., 2018, In: Rheumatology. 57, 9, p. 1533-1540Research output: Contribution to journal › Article › peer-review
Open Access -
2017
Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?
Dennison, E. M., Jameson, K. A., Marks, J., Watson, K., Hyrich, K., Symmons, D. & Cooper, C. C., 1 Apr 2017, In: Rheumatology (Print). 56, 4, p. 663-665 3 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Drug-specific risk and characteristics of lupus and vasculitis-like events in rheumatoid arthritis patients treated with TNFi: results from BSRBR-RA
Jani, M., Dixon, W., Kearsley-Fleet, L., Bruce, I., Chinoy, H., Barton, A., Lunt, M., Watson, K., BSRBR-RA Control Centre Consortium, Symmons, D. & Hyrich, K., 21 Jan 2017, In: RMD Open. 3, 1, p. e000314Research output: Contribution to journal › Article › peer-review
Open Access -
Mortality in Patients with Interstitial Lung Disease Treated with Rituximab or TNFi as a First Biologic
Druce, K., Iqbal, K., Watson, K., Symmons, D., BSRBR-RA Investigators Group, Hyrich, K. & Kelly, C., 1 Jul 2017, In: RMD Open. 3, 1, e000473.Research output: Contribution to journal › Article › peer-review
Open Access -
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis
Low, A., Symmons, D., Lunt, M., Mercer, L., Gale, C., Watson, K., Dixon, W. & Hyrich, K., 2017, In: Annals of the rheumatic diseases. 76, 4, p. 654-660Research output: Contribution to journal › Article › peer-review
Open Access -
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
BSRBR Control Centre Consortium, Mercer, L., Galloway, J. B., Lunt, M., Davies, R., Low, A., Dixon, W., Watson, K., Symmons, D. & Hyrich, K., 1 Mar 2017, In: Annals of the rheumatic diseases. 76, 3, p. 497-503 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: An observational study from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Kihara, M., Davies, R., Kearsley-Fleet, L., Watson, K., Lunt, M., Symmons, D. & Hyrich, K., Feb 2017, In: Clinical Rheumatology. 36, 2, p. 241-250 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2016
Association between ischaemic stroke and tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis.
Low, A. S. L., Lunt, M., Mercer, L. K., Watson, K. D., Dixon, W. G., Symmons, D. P. M. & Hyrich, K. L., 2016, In: Arthritis & rheumatology (Hoboken, N.J.). 68, 6, p. 1337–1345Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness and Safety of TNF Inhibitors in Adults with Juvenile Idiopathic Arthritis
Kearsley-Fleet, L., McErlane, F., Foster, H. E., Lunt, M., Watson, K., Symmons, D. & Hyrich, K., 7 Oct 2016, In: RMD Open. 2, 2, e000273.Research output: Contribution to journal › Article › peer-review
Open Access -
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNFi or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis
BSRBR Control Centre Consortium, Silva-Fernandez, L., Lunt, M., Kearsley-Fleet, L., Watson, K., Dixon, W., Symmons, D. & Hyrich, K., Nov 2016, In: Rheumatology. 55, 11, p. 2033-2039 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2015
The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era.
Morgan, C., Mcbeth, J., Cordingley, L., Watson, K., Hyrich, K. L., Symmons, D. P. M. & Bruce, I. N., 2015, In: Rheumatology (Print). 54, 10, p. 1780-1791 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2014
The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the BSRBR-RA
Závada, J., Lunt, M., Davies, R., Low, A. S. L., Mercer, L. K., Galloway, J. B., Watson, K. D., Symmons, D. P. & Hyrich, K. L., Jan 2014, In: Annals of the rheumatic diseases. 73, 1, p. 252-255 3 p.Research output: Contribution to journal › Article › peer-review
-
2013
Anti-TNF therapy in women with rheumatoid arthritis with a history of carcinoma in situ of the cervix
Mercer, L. K., Low, A. S. L., Galloway, J. B., Watson, K. D., Lunt, M., Symmons, D. P. M. & Hyrich, K. L., Jan 2013, In: Annals of the rheumatic diseases. 72, 1, p. 143-144 1 p.Research output: Contribution to journal › Article › peer-review
-
Biologic treatment response among adults with juvenile idiopathic arthritis: Results from the British society for rheumatology biologics register
McErlane, F., Foster, H. E., Davies, R., Lunt, M., Watson, K. D., Symmons, D. P. M. & Hyrich, K. L., Oct 2013, In: Rheumatology. 52, 10, p. 1905-1913 8 p., ket248.Research output: Contribution to journal › Article › peer-review
-
Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK
Davies, R., Dixon, W., Lunt, M., Watson, K. & Hyrich, K., 2013, In: Annals of the rheumatic diseases. 72, 3, p. 461-2 2 p.Research output: Contribution to journal › Article › peer-review
-
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
Mercer, L. K., Davies, R., Galloway, J. B., Low, A., Lunt, M., Dixon, W. G., Watson, K. D., Symmons, D. P. M. & Hyrich, K. L., Jan 2013, In: Rheumatology. 52, 1, p. 91-98 7 p., kes350.Research output: Contribution to journal › Article › peer-review
-
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register
Galloway, J. B., Mercer, L. K., Moseley, A., Dixon, W. G., Ustianowski, A. P., Helbert, M., Watson, K. D., Lunt, M., Hyrich, K. L. & Symmons, D. P. M., Feb 2013, In: Annals of the rheumatic diseases. 72, 2, p. 229-234 5 p.Research output: Contribution to journal › Article › peer-review
-
2012
Effectiveness of rituximab in patients with rheumatoid arthritis: Observational study from the British society for rheumatology biologics register
Soliman, M. M., Hyrich, K. L., Lunt, M., Watson, K. D., Symmons, D. P. M. & Ashcroft, D. M., Feb 2012, In: Journal of Rheumatology. 39, 2, p. 240-246 6 p.Research output: Contribution to journal › Article › peer-review
-
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register
Soliman, M. M., Hyrich, K. L., Lunt, M., Watson, K. D., Symmons, D. P. M. & Ashcroft, D. M., Aug 2012, In: Arthritis Care & Research. 64, 8, p. 1108-1115 7 p.Research output: Contribution to journal › Article › peer-review
-
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: Longitudinal results from the British Society for Rheumatology Biologics Register
Mercer, L. K., Green, A. C., Galloway, J. B., Davies, R., Lunt, M., Dixon, W. G., Watson, K. D., Symmons, D. P. M., Hyrich, K. L., Maiden, N., Price, T., Hopkinson, N., O'Reilly, S., Hordon, L., Griffiths, I., Porter, D., Capell, H., Hassell, A., Benitha, R. & Choy, E. & 19 others, , Jun 2012, In: Annals of the rheumatic diseases. 71, 6, p. 869-874 5 p.Research output: Contribution to journal › Article › peer-review
-
2011
Anti-TNF therapies and pregnancy: Outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
Verstappen, S. M. M., King, Y., Watson, K. D., Symmons, D. P. M., Hyrich, K. L., Panayi, G., Scott, D. G. I., Bamji, A. & Bax, D., May 2011, In: Annals of the rheumatic diseases. 70, 5, p. 823-826 3 p.Research output: Contribution to journal › Article › peer-review
-
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: Updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Fu, B., Ustianowski, A. P., Watson, K. D., Lunt, M. & Symmons, D. P. M., Jan 2011, In: Rheumatology. 50, 1, p. 124-131 7 p.Research output: Contribution to journal › Article › peer-review
-
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008
Hyrich, K. L., Watson, K. D., Lunt, M. & Symmons, D. P. M., Jan 2011, In: Rheumatology. 50, 1, p. 117-123 6 p.Research output: Contribution to journal › Article › peer-review
-
Detection and evaluation of a drug safety signal concerning pancreatic cancer: Lessons from a joint approach of three European biologics registers
Strangfeld, A., Hyrich, K., Askling, J., Arkema, E., Davies, R., Listing, J., Neovius, M., Simard, J., Symmons, D., Watson, K. & Zink, A., Jan 2011, In: Rheumatology. 50, 1, p. 146-151 5 p.Research output: Contribution to journal › Article › peer-review
-
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
Soliman, M. M., Ashcroft, D. M., Watson, K. D., Lunt, M., Symmons, D. P. M. & Hyrich, K. L., Apr 2011, In: Annals of the rheumatic diseases. 70, 4, p. 583-589 6 p.Research output: Contribution to journal › Article › peer-review
-
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register
Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Ustianowski, A. P., Helbert, M., Watson, K. D., Lunt, M. & Symmons, D. P. M., Oct 2011, In: Annals of the rheumatic diseases. 70, 10, p. 1810-1814 4 p.Research output: Contribution to journal › Article › peer-review
-
The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Watson, K. D., Lunt, M. & Symmons, D. P. M., Jul 2011, In: Rheumatology. 50, 7, p. 1341-1342 1 p., ker146.Research output: Contribution to journal › Article › peer-review
-
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register
Davies, R., Galloway, J. B., Watson, K. D., Lunt, M., Symmons, D. P. M., Hyrich, K. L., Griffiths, I., Isenberg, D., Panayi, G., Scott, D. G. I., Bamji, A., Bax, D., Hogg, M. & Taylor, N., Oct 2011, In: Annals of the rheumatic diseases. 70, 10, p. 1831-1834 3 p.Research output: Contribution to journal › Article › peer-review
-
2010
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR)
Dixon, W. G., Hyrich, K. L., Watson, K. D., Lunt, M., Galloway, J., Ustianowski, A. & Symmons, D. P. M., Mar 2010, In: Annals of the rheumatic diseases. 69, 3, p. 522-528 6 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register
Saad, A. A., Ashcroft, D. M., Watson, K. D., Symmons, D. P. M., Noyce, P. R. & Hyrich, K. L., 2010, In: Rheumatology. 49, 4, p. 697-705Research output: Contribution to journal › Article › peer-review
-
Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis
Harrison, M. J., Lunt, M., Verstappen, S. M. M., Watson, K. D., Bansback, N. J. & Symmons, D. P. M., 11 Feb 2010, In: Health and Quality of Life Outcomes. 8, 21.Research output: Contribution to journal › Article › peer-review
-
Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies
Saad, A. A., Ashcroft, D. M., Watson, K. D., Symmons, D. P. M., Noyce, P. R. & Hyrich, K. L., Mar 2010, In: Arthritis Care & Research. 62, 3, p. 345-353 8 p.Research output: Contribution to journal › Article › peer-review
-
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: Results from the British Society for Rheumatology Biologics Register
Dixon, W. G., Hyrich, K. L., Watson, K. D., Lunt, M. & Symmons, D. P. M., Jun 2010, In: Annals of the rheumatic diseases. 69, 6, p. 1086-1091 5 p.Research output: Contribution to journal › Article › peer-review
-
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for Rheumatology Biologics Register
Dixon, W. G., Watson, K. D., Lunt, M., Mercer, L. K., Hyrich, K. L., Symmons, D. P. M., Maiden, N., Price, T., Hopkinson, N., O'Reilly, S., Hordon, L., Griffiths, I., Porter, D., Capell, H., Hassell, A., Benitha, R., Choy, E., Walsh, D., Emery, P. & Knight, S. & 13 others, , Jun 2010, In: Arthritis Care & Research. 62, 6, p. 755-763 8 p.Research output: Contribution to journal › Article › peer-review
-
No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
Lunt, M., Watson, K. D., Dixon, W. G., Symmons, D. P. M. & Hyrich, K. L., Nov 2010, In: Arthritis Care & Research. 62, 11, p. 3145-3153 8 p.Research output: Contribution to journal › Article › peer-review
-
Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: Results from the British Society for Rheumatology Biologics Register
Verstappen, S. M. M., Watson, K. D., Lunt, M., McGrother, K., Symmons, D. P. M. & Hyrich, K. L., 5 May 2010, In: Rheumatology. 49, 8, p. 1570-1577 7 p., keq131.Research output: Contribution to journal › Article › peer-review
-
2009
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
Hyrich, K. L., Deighton, C., Watson, K. D., Symmons, D. P. M., Lunt, M., Maiden, N., Price, T., Hopkinson, N., O'Reilly, S., Hordon, L., Griffiths, I., Porter, D., Capell, H., Hassell, A., Benitha, R., Choy, E., Walsh, D., Emery, P., Knight, S. & Bruce, I. & 15 others, , 2009, In: Rheumatology. 48, 10, p. 1323-1327 4 p.Research output: Contribution to journal › Article › peer-review